Document Detail


Tumour markers in colorectal cancer.
MedLine Citation:
PMID:  3201159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Carcinoembryonic antigen (CEA) is still the best marker both for primary diagnosis and post-treatment monitoring of patients with colorectal cancer. Monoclonal antibodies, especially CA 19-9 and CA 50 may give additional information whereas CA 125 seems to be of no value in patients with colorectal cancer. The sensitivity of CEA determination for Dukes' A carcinomas is as low as 30%, but increases to 85% for Dukes' D carcinomas. The best clinical benefit of CEA is in postoperative monitoring of surgically treated patients with colorectal cancer. The sensitivity and specificity for distant metastases are 85%. The sensitivity in the detection of local recurrence is low (40%) but the specificity is still high (80%). A high CEA level postoperatively strongly suggests either local recurrence or disseminated disease, but a negative value does not exclude their presence. If CEA is negative both preoperatively and one month postoperatively, CA 19-9 or CA 50 may be used in the monitoring of these patients.
Authors:
P J Roberts
Related Documents :
19396699 - Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.
7511919 - Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer.
9179059 - Increased cathepsin d level in the serum of patients with metastatic breast carcinoma d...
9877089 - Comparison of tissue polypeptide antigen (tpa) with cancer antigen 15-3 (ca 15-3) and c...
4053109 - Carcinoembryonic antigen in experimental rat gastrointestinal carcinoma.
25347269 - The cpg island methylator phenotype in breast cancer is associated with the lobular sub...
14578209 - Progression to malignancy in the polyoma middle t oncoprotein mouse breast cancer model...
11550579 - Early termination of breast-feeding in periurban santo domingo, dominican republic: mot...
17448709 - Bisphosphonates and osteonecrosis of the jaws: science and rationale.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Scandinavian journal of gastroenterology. Supplement     Volume:  149     ISSN:  0085-5928     ISO Abbreviation:  Scand. J. Gastroenterol. Suppl.     Publication Date:  1988  
Date Detail:
Created Date:  1989-01-26     Completed Date:  1989-01-26     Revised Date:  2008-02-13    
Medline Journal Info:
Nlm Unique ID:  0437034     Medline TA:  Scand J Gastroenterol Suppl     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  50-8     Citation Subset:  IM    
Affiliation:
University Central Hospital, Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / diagnostic use
Antigens, Tumor-Associated, Carbohydrate / analysis*
Carcinoembryonic Antigen / analysis*
Colorectal Neoplasms / diagnosis*
Humans
Postoperative Care
Tumor Markers, Biological / analysis*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antigens, Tumor-Associated, Carbohydrate; 0/Carcinoembryonic Antigen; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The pathological grading and staging of rectal cancer.
Next Document:  Preoperative nutrition.